BRIEF published on 10/15/2024 at 15:05, 1 month 5 days ago KindlyMD Announces $500,000 Stock Repurchase Program Shareholder Value Market Conditions Stock Repurchase Healthcare Company KindlyMD
PRESS RELEASE published on 10/15/2024 at 15:00, 1 month 5 days ago KindlyMD(TM) Announces $500,000 Share Repurchase Program KindlyMD, Inc. authorizes a $500,000 stock repurchase program, aiming to enhance shareholder value. The program may be made through various methods, considering market conditions Shareholder Value Stock Repurchase KindlyMD Patient-first Healthcare Integrated Therapies
BRIEF published on 10/08/2024 at 15:05, 1 month 12 days ago KindlyMD Secures Contract with UnitedHealthcare Healthcare Expansion Utah KindlyMD UnitedHealthcare Health Insurance
PRESS RELEASE published on 10/08/2024 at 15:00, 1 month 12 days ago KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States KindlyMD, Inc. announces its new contract with UnitedHealthcare Insurance, expanding coverage and access for patients in Utah, leading to potential revenue growth Utah Contract KindlyMD UnitedHealthcare Expanded Coverage
BRIEF published on 10/01/2024 at 15:05, 1 month 19 days ago KindlyMD(TM) to Participate in Upcoming October Conferences Medical Cannabis KindlyMD Tim Pickett Benzinga Conference LD Micro
PRESS RELEASE published on 10/01/2024 at 15:00, 1 month 19 days ago KindlyMD(TM) to Participate in Upcoming October Conferences KindlyMD, Inc. CEO to participate in investor conferences discussing medical cannabis experience best practices. Company integrates healthcare strategies with alternative therapies Investor Conferences Medical Cannabis KindlyMD Inc. Healthcare Data Alternative Therapies
BRIEF published on 09/12/2024 at 15:05, 2 months 8 days ago KindlyMD Recognized with Healthcare AI Impact Award 2024 AI Healthcare Medical Cannabis Awards Patient Data
PRESS RELEASE published on 09/12/2024 at 15:00, 2 months 8 days ago KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024 KindlyMD, Inc. wins Healthcare AI Impact Award 2024 for innovative AI-driven patient diagnostics, focusing on medical cannabis use in treatment to improve patient outcomes. Learn more at www.kindlymd.com Patient Outcomes Medical Cannabis KindlyMD Inc. Healthcare AI Impact Award 2024 AI-driven Patient Diagnostics
BRIEF published on 08/29/2024 at 15:05, 2 months 22 days ago KindlyMD Appoints Jeremy Joyal, MD as Medical Director Healthcare Pain Management KindlyMD Medical Director Jeremy Joyal
PRESS RELEASE published on 08/29/2024 at 15:00, 2 months 22 days ago KindlyMD(TM) Appoints Jeremy Joyal, MD as Medical Director KindlyMD, Inc. appoints Dr. Joyal, MD, as Medical Director to oversee clinical practices and develop pain management program protocols. Dr. Joyal brings expertise in Anesthesiology, Pain Medicine, and Addiction Medicine Anesthesiology Pain Management KindlyMD Medical Director Dr. Joyal
Published on 11/21/2024 at 13:30, 22 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 22 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 52 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 52 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 52 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 37 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 54 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 32 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
